GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Developments PLC (AQSE:ANA) » Definitions » Current Accrued Expense

Ananda Developments (AQSE:ANA) Current Accrued Expense : £0.00 Mil (As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Ananda Developments Current Accrued Expense?

Ananda Developments's Current Accrued Expense for the quarter that ended in Jul. 2023 was £0.00 Mil.


Ananda Developments Current Accrued Expense Historical Data

The historical data trend for Ananda Developments's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Developments Current Accrued Expense Chart

Ananda Developments Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
Current Accrued Expense
- - - - -

Ananda Developments Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Ananda Developments Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Ananda Developments Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Ananda Developments's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Developments (AQSE:ANA) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Developments PLC provides investment to healthcare market for the companies that develop medicinal or therapeutic cannabis derivatives, or related products including nutraceuticals, dietary supplements, and cosmetic products which contain Cannabis or hemp derived cannabinoids.

Ananda Developments (AQSE:ANA) Headlines

No Headlines